Sign in
4

Changes in Ownership

Propanc Biopharma, Inc. Filed Acc 0000891839-16-000265

Director acquired 17,654,470 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kenyon Julian Norman Director 2015-02-04 Other acquisition +17,654,470 28,466,534 D
Derivatives
Kenyon Julian Norman Director 2016-04-14 Grant or award · Stock Option (Right to Buy) +71,500,000 71,500,000 D
Loading xslF345X03/edgar.xml…